NYSE: CUZCousins Properties Inc Stock
$29.64-0.29 (-0.97%)
Updated Mar 27, 2025
CUZ Price
$29.64
Fair Value Price
N/A
Market Cap
$4.97B
52 Week Low
$21.58
52 Week High
$32.55
P/E
98.8x
P/B
1.03x
P/S
5.49x
PEG
0.86x
Dividend Yield
3.24%
Revenue
$856.76M
Earnings
$45.96M
Gross Margin
67.2%
Operating Margin
19.66%
Profit Margin
5.4%
Debt to Equity
0.81
Operating Cash Flow
$400M
Beta
1.04
Next Earnings
Apr 23, 2025
Ex-Dividend
N/A
Next Dividend
N/A
CUZ Overview
Cousins Properties Inc is a Real Estate Investment Trust (REIT) that invests in office buildings in Atlanta, Chapel Hill, Charlotte, Austin, Phoenix, and Tampa. Notable properties include CNN Center, Omni Coliseum, 191 Peachtree Tower, and Emory Point in Atlanta. The company's portfolio consists of 18.3 million square feet of office space and 620,000 square feet of other space. The company was founded in 1958 and is headquartered in Atlanta, GA.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CUZ's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
B
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Office REIT
Industry Rating
F
CUZ
Ranked#4 of 22
Ranked#4 of 22
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $14.07 | B | |
| $37.70 | C | |
| $31.65 | C |
Be the first to know about important CUZ news, forecast changes, insider trades & much more!
CUZ News
Overview
Due Diligence Score
–
Industry Average (18)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CUZ scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CUZ ($29.64) is trading above its intrinsic value of $13.58, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CUZ is poor value based on its earnings relative to its share price (98.8x), compared to the US market average (31.08x)
P/E vs Market Valuation
CUZ is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more CUZ due diligence checks available for Premium users.
Valuation
CUZ price to earnings (PE)
For valuing profitable companies with steady earnings
Company
98.8x
Industry
313.22x
Market
31.08x
CUZ is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CUZ is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
CUZ price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.03x
Industry
0.96x
CUZ is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CUZ price to earnings growth (PEG)
For valuing profitable companies with growth potential
CUZ is good value based... subscribe to Premium to read more.
PEG Value Valuation
CUZ's financial health
Profit margin
Revenue
$225.3M
Net Income
$13.6M
Profit Margin
6.1%
CUZ's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$8.8B
Liabilities
$3.9B
Debt to equity
0.81
CUZ's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
CUZ's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$129.0M
Investing
-$1.1B
Financing
$853.7M
CUZ vs Office REIT Stocks
Cousins Properties Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.